Your browser doesn't support javascript.
Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
Zinszer, Kate; McKinnon, Britt; Bourque, Noémie; Pierce, Laura; Saucier, Adrien; Otis, Alexandra; Cheriet, Islem; Papenburg, Jesse; Hamelin, Marie-Ève; Charland, Katia; Carbonneau, Julie; Zahreddine, Monica; Savard, Ashley; Fortin, Geneviève; Apostolatos, Alexander; Haley, Nancy; Ratté, Nathalie; Laurin, Isabel; Nguyen, Cat Tuong; Conrod, Patrica; Boivin, Guy; De Serres, Gaston; Quach, Caroline.
  • Zinszer K; University of Montreal, Montreal, Quebec, Canada.
  • McKinnon B; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Bourque N; University of Montreal, Montreal, Quebec, Canada.
  • Pierce L; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Saucier A; University of Toronto, Toronto, Ontario, Canada.
  • Otis A; University of Montreal, Montreal, Quebec, Canada.
  • Cheriet I; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Papenburg J; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Hamelin MÈ; University of Montreal, Montreal, Quebec, Canada.
  • Charland K; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Carbonneau J; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Zahreddine M; University of Montreal, Montreal, Quebec, Canada.
  • Savard A; Montreal Children's Hospital, Montreal, Quebec, Canada.
  • Fortin G; McGill University Health Centre, Montreal, Quebec, Canada.
  • Apostolatos A; Research Centre Laval University, Quebec City, Quebec, Canada.
  • Haley N; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Ratté N; Research Centre Laval University, Quebec City, Quebec, Canada.
  • Laurin I; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Nguyen CT; Centre for Public Health Research, Montreal, Quebec, Canada.
  • Conrod P; University of Montreal, Montreal, Quebec, Canada.
  • Boivin G; Centre for Public Health Research, Montreal, Quebec, Canada.
  • De Serres G; University of Montreal, Montreal, Quebec, Canada.
  • Quach C; Direction régionale de la santé publique du Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec, Canada.
JAMA Netw Open ; 4(11): e2135975, 2021 11 01.
Article in English | MEDLINE | ID: covidwho-1527396
ABSTRACT
Importance Quebec prioritized in-person learning after the first wave of the COVID-19 pandemic, with school closures being implemented temporarily in selected schools or in hot-spot areas. Quebec's decision to keep most schools open was controversial, especially in Montreal, which was the epicenter of Canada's first and second waves; therefore, understanding the extent to which children were infected with SARS-CoV-2 provides important information for decisions about school closures.

Objective:

To estimate the seroprevalence of SARS-CoV-2 antibodies in children and teenagers in 4 neighborhoods of Montreal, Canada. Design, Setting, and

Participants:

This cohort study (the Enfants et COVID-19 Étude de séroprévalence [EnCORE] study) enrolled a convenience sample of children aged 2 to 17 years between October 22, 2020, and March 22, 2021, in Montreal, Canada. Exposures Potential exposure to SARS-CoV-2. Main Outcomes and

Measures:

The main outcome was seroprevalence of SARS-CoV-2 antibodies, collected using dried blood spots (DBSs) and analyzed with a research-based enzyme-linked immunosorbent assay (ELISA). Parents also completed an online questionnaire that included questions on self-reported COVID-19 symptoms and tests, along with sociodemographic questions.

Results:

This study included 1632 participants who provided a DBS sample from 30 day cares, 22 primary schools, and 11 secondary schools. The mean (SD) age of the children who provided a DBS sample was 9.0 (4.4) years; 801 (49%) were female individuals, with 354 participants (22%) from day cares, 725 (44%) from primary schools, and 553 (34%) from secondary schools. Most parents had at least a bachelor's degree (1228 [75%]), and 210 (13%) self-identified as being a racial or ethnic minority. The mean seroprevalence was 5.8% (95% CI, 4.6%-7.0%) but increased over time from 3.2% (95% CI, 0.7%-5.8%) in October to November 2020 to 8.4% (95% CI, 4.4%-12.4%) in March to April 2021. Of the 95 children with positive SARS-CoV-2 antibody results, 78 (82%) were not tested or tested negative with reverse transcription-polymerase chain reaction (RT-PCR) testing, and all experienced mild (49 [52%]) or no clinical symptoms (46 [48%]). The children of parents who self-identified as belonging to a racial and ethnic minority group were more likely to be seropositive compared with children of White parents (adjusted seroprevalence ratio, 1.9; 95% CI, 1.1-2.6). Conclusions and Relevance These results provide a benchmark of the seroprevalence status in Canadian children. The findings suggest that there was more transmission occurring in children compared with what was being detected by RT-PCR, although children experienced few or mild symptoms. It will be important to continue monitoring the serological status of children, particularly in the context of new COVID-19 variants of concern and in the absence of mass vaccination campaigns targeting young children.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ethnicity / COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article Affiliation country: Jamanetworkopen.2021.35975

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ethnicity / COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article Affiliation country: Jamanetworkopen.2021.35975